Skip to main content
Indietro

Antimicrobial Drugs in Microbiology

I pulsanti di controllo sono stati cambiati in modalità "navigazione".
1/39
  • Phosphonomycin mechanism

    Inhibits conversion of UDP-NAG to UDP-NAM by blocking pyruvyl transferase.

  • Cycloserine action

    Inhibits enzymes adding alanines to peptide side-chains in bacterial cell wall synthesis.

  • Bacitracin target

    Blocks secretion of NAG and NAM by binding bactoprenol and preventing its dephosphorylation.

  • Vancomycin mode of action

    Binds terminal D-ala-D-ala chains on NAM peptides, preventing transglycosylation and transpeptidation.

  • Beta-lactams function

    Inhibit transpeptidation cross-linking peptide side-chains of peptidoglycan backbone (includes penicillins, cephalosporins).

  • Aminoglycosides effect on protein synthesis

    Bind 30S ribosomal subunit causing misreading of mRNA and inhibiting protein synthesis.

  • Tetracyclines binding site

    Bind 30S ribosomal subunit at tRNA docking site (A site), blocking tRNA attachment.

  • Chloramphenicol mechanism

    Blocks enzymatic site of 50S ribosomal subunit, preventing peptide bond formation.

  • Macrolides, Lincosamides, Streptogramins action

    Bind 50S subunit preventing ribosome movement from one codon to the next.

  • Mupirocin specificity

    Selective binding to bacterial tRNA carrying leucine, preventing isoleucine incorporation into polypeptides.

  • Oxazolidinones (Linezolid) effect

    Block formation of stable 70S initiation complex, preventing translation.

  • Gramicidin action on membranes

    Forms pores across cytoplasmic membrane, damaging membrane integrity.

  • Polymyxin characteristics

    Disrupts cytoplasmic membranes, effective against gram-negative bacteria but toxic to human kidneys.

  • Dapsone mechanism

    Interferes with folic acid synthesis, acting as an antimetabolite.

  • Sulfonamides mode of action

    PABA analogs that bind enzyme producing dihydrofolic acid, inhibiting folic acid synthesis.

  • Trimethoprim target

    Binds enzyme converting dihydrofolic acid to tetrahydrofolic acid, blocking folic acid pathway.

  • Fluoroquinolones mechanism

    Inhibit DNA gyrase, essential for DNA coiling and uncoiling during replication.

  • Nitroimidazoles action

    Reduced by anaerobic bacteria to generate toxic free radicals that damage DNA causing cell death.

  • Ethambutol effect on Mycobacteria

    Prevents formation of mycolic acid, a key cell wall component in Mycobacteria.

  • Isoniazid mechanism

    Blocks gene for enzyme forming mycolic acid in Mycobacteria.

  • Pyrazinamide action

    Disrupts membrane transport and prevents repair of damaged proteins in Mycobacteria.

  • Rifamycin target

    Binds bacterial RNA polymerase, preventing RNA transcription.

  • Clofazimine mechanism

    Binds DNA of Mycobacterium leprae, preventing replication and transcription.

  • Fomiversen antiviral action

    Antisense nucleic acid drug complementary to mRNA, blocking viral protein synthesis.

  • Amantadine and Rimantadine function

    Inhibit viral uncoating by neutralizing acidic environment of phagolysosomes.

  • Protease inhibitors in antivirals

    Block active site of HIV protease enzyme, preventing viral protein processing.

  • Acyclovir activation and action

    Activated by viral kinase; inhibits viral DNA and RNA synthesis as a nucleotide analog.

  • Azidothymidine (AZT) mechanism

    Reverse transcriptase inhibitor activated by cell kinase, incorporated into viral DNA to inhibit synthesis.

  • Neuraminidase inhibitors

    Prevent Influenza virus from attaching to host cells, blocking viral spread.

  • Echinocandins antifungal action

    Inhibit synthesis of glucan subunit of fungal cell wall.

  • Polyenes mode of action

    Bind ergosterol forming pores in fungal membranes causing leakage of cytoplasmic contents.

  • Azoles antifungal mechanism

    Inhibit synthesis of ergosterol, disrupting fungal cell membrane integrity.

  • 5-Fluorocytosine action

    Converted by fungal enzyme into 5-fluorouracil, inhibiting RNA function and nucleic acid synthesis.

  • Benzimidazole antihelmintic effect

    Inhibit microtubule formation and glucose uptake in helminths.

  • Praziquantel and Ivermectin action

    Increase cell membrane permeability, disrupting helminth cytoplasmic membranes.

  • Atovaquone antiprotozoan mechanism

    Interrupts electron transport chain in protozoa, inhibiting metabolism.

  • Nitroimidazole antiprotozoan action

    Reduced under anaerobic conditions to toxic free radicals damaging protozoan DNA.

  • Pentamidine antiprotozoan effect

    Binds nucleic acids inhibiting replication, transcription, and translation.

  • Quinolones (chloroquine) antiprotozoan action

    Mechanism unknown but used to treat protozoan infections.